Last reviewed · How we verify
Natesto testosterone intranasal gel — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Natesto testosterone intranasal gel (Natesto testosterone intranasal gel) — VA Office of Research and Development.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Natesto testosterone intranasal gel TARGET | Natesto testosterone intranasal gel | VA Office of Research and Development | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Natesto testosterone intranasal gel CI watch — RSS
- Natesto testosterone intranasal gel CI watch — Atom
- Natesto testosterone intranasal gel CI watch — JSON
- Natesto testosterone intranasal gel alone — RSS
Cite this brief
Drug Landscape (2026). Natesto testosterone intranasal gel — Competitive Intelligence Brief. https://druglandscape.com/ci/natesto-testosterone-intranasal-gel. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab